DetectaChem/MD-Bio Announce National COVID-19 Sniffing K9 Program
Game-changing MD-Bio COVID dogs are now available for purchase and rentals for rapid screening of COVID-19 at large venues, schools, businesses and more.
SUGAR LAND, Texas, March 23, 2022 /PRNewswire/ -- DetectaChem and its subsidiary MD-Bio, the global leaders in innovative threat detection solutions used extensively by the U.S. Department of Defense, U.S. Homeland Security, law enforcement, first responder and public health agencies around the world, today announce the launch of their COVID K9 screening and training program.
As the world begins to get back to normal, COVID-19 screening is more important than ever. MD-Bio COVID K9s provide a game-changing solution for the accurate, non-intrusive and immediate detection of COVID-19. COVID K9s are able to be deployed at events, businesses, schools and more to help people safely return to normal. Not only can the K9s detect the virus on individuals, but they offer the only solution to pre-screen areas by detecting COVID-19 on surfaces.
"We live in a world where COVID-19 is always going to be a concern," says DetectaChem and MD-Bio COO, Travis Kisner. "The COVID K9s help us bridge that gap between getting back to normal and making sure that we are prioritizing our health and safety when we gather."
There is significant precedent for canines being able to detect biological targets such as certain cancers and Parkinson's Disease. With senses of smell up to 10,000 times better than humans, MD-Bio COVID K9s are trained to sniff for the unique volatile organic compounds (VOCs) that an active COVID-19 infection produces in humans that is emitted through sweat, saliva and breath.
In a series of blind studies, the COVID K9s detection on humans matched 98% to RT-PCR results. In certain instances, the K9s accurately detected COVID-19 infections backed by RT-PCR results when antigen tests provided a false negative. The MD-Bio K9s have been successfully utilized at the U.S. border, state health agencies, schools, hospitals, events, businesses and more.
MD-Bio COVID K9s are available for purchase and rental now.
About DetectaChem and MD-Bio
Established in 2005, DetectaChem is a Texas, USA-based manufacturer of rapidly deployable, handheld, intelligent and easy-to-operate threat detection systems used around the world. Subsidiary company MD-Bio offers a variety of COVID-19 testing solutions and screening products. DetectaChem and MD-Bio are proud supporters of the U.S. military, law enforcement and all first responders. More information at www.MDBio.com and www.DetectaChem.com.
Press Contact:
Bryan Beaty
[email protected]
+1.855.573.3537
SOURCE DetectaChem
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article